ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease
We provide practical guidance by evidence-based recommendations to clinicians for each of the CTDs. In many cases there is low certainty or absence of evidence and we encourage further research to fill these gaps.
Authors
- Benjamin A. Fisher (ORCID: https://orcid.org/0000-0003-4631-549X)
- Jens Vikse (ORCID: https://orcid.org/0000-0001-9045-3588)
- Anna‐Maria Hoffmann‐Vold (ORCID: https://orcid.org/0000-0001-6467-7422)
- Thomy Tonia (ORCID: https://orcid.org/0000-0001-7896-6188)
- Elisabetta Renzoni (ORCID: https://orcid.org/0000-0002-1118-797X)
- Ingrid E. Lundberg (ORCID: https://orcid.org/0000-0002-6068-9212)
- Tamera J. Corte (ORCID: https://orcid.org/0000-0002-5076-8929)
- Vincent Cottin (ORCID: https://orcid.org/0000-0002-5591-0955)
- Venerino Poletti (ORCID: https://orcid.org/0000-0002-8634-2284)
- Tanja Stamm (ORCID: https://orcid.org/0000-0003-3073-7284)
- Ana-Maria Gheorghiu
- Ilaria Galetti (ORCID: https://orcid.org/0000-0001-9595-7582)
- Jibril Mohammed (ORCID: https://orcid.org/0000-0001-7466-7973)
- Paul Studenic (ORCID: https://orcid.org/0000-0002-8895-6941)
- Nicola Sverzellati (ORCID: https://orcid.org/0000-0002-4820-3785)
- Elena Bargagli (ORCID: https://orcid.org/0000-0002-8351-3703)
- G. R. Brown (ORCID: https://orcid.org/0000-0002-4101-3823)
- Aurélie Fabre (ORCID: https://orcid.org/0000-0001-8176-1386)
- Yannick Allanore (ORCID: https://orcid.org/0000-0002-6149-0002)
- Nikoleta Bizymi (ORCID: https://orcid.org/0000-0001-5199-1519)
- Katerina M. Antoniou (ORCID: https://orcid.org/0009-0006-0207-4582)
- Catharina C. Moor (ORCID: https://orcid.org/0000-0002-5295-2877)
- Blin Nagavci (ORCID: https://orcid.org/0000-0002-6626-2842)
- Mary E. Strek (ORCID: https://orcid.org/0000-0002-7671-1023)
- Bruno Crestani (ORCID: https://orcid.org/0000-0002-2961-3455)
- Britta Maurer (ORCID: https://orcid.org/0000-0001-9385-8097)
- Jon T. Giles (ORCID: https://orcid.org/0000-0002-8792-0402)
- Oliver Distler
- Philippe Dieudé (ORCID: https://orcid.org/0000-0002-4814-0307)
- Michael Kreuter
- Ulf Müller-Ladner
Institutions
- Université Claude Bernard Lyon 1 (FR)
- University College Dublin (IE)
- University of Siena (IT)
- University of Bern (CH)
- University of Parma (IT)
- University of Suffolk (GB)
- Oslo University Hospital (NO)
- Cedars-Sinai Medical Center (US)
- The University of Sydney (AU)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Statistics Austria (AT)
- Karolinska University Hospital (SE)
- University of Crete (GR)
- University of Freiburg (DE)
- Carol Davila University of Medicine and Pharmacy (RO)
- Johannes Gutenberg University Mainz (DE)
- Justus-Liebig-Universität Gießen (DE)
- University of Zurich (CH)
- Université Paris Cité (FR)
- Royal Prince Alfred Hospital (AU)
- Royal Brompton & Harefield NHS Foundation Trust (GB)
- Stavanger University Hospital (NO)
- University Hospital of Bern (CH)
- University Medical Center Freiburg (DE)
- Erasmus MC (NL)
- Karolinska Institutet (SE)
- Endangered Language Fund (US)
- National Institute for Health and Care Research (GB)
- University of Chicago (US)
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
- Hôpital Cochin (FR)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Assistance Publique – Hôpitaux de Paris (FR)
- University Hospital of Zurich (CH)
- St. Vincent's University Hospital (IE)
- Kerckhoff Klinik (DE)
- Institute of Social and Preventive Medicine (CH)
- Hôpital Louis Pradel (FR)
- Hôpital Bichat-Claude-Bernard (FR)
- European League Against Rheumatism (CH)
- NIHR Birmingham Biomedical Research Centre (GB)
- University of Bergen (NO)
- Medical University of Vienna (AT)
- University of Birmingham (GB)
- Erasmus University Rotterdam (NL)
- Bayero University Kano (NG)
- University of Stavanger (NO)
- University of Bologna (IT)
Publication Details
- Journal
- European Respiratory Journal
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1183/13993003.02533-2024
- Citations
- 13
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 19.74
Funders
- Boehringer Ingelheim
- Amgen
- Bristol-Myers Squibb
- Pulmonary Fibrosis Foundation
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Celgene
- FibroGen
- United Therapeutics Corporation
- European Respiratory Society
- Kiniksa Pharmaceuticals
- Celltrion
- Argenx
- Shionogi
- Reumatikerförbundet
- Schweizerische Akademie der Medizinischen Wissenschaften
- Servier
- Swedish Orphan Biovitrum
- Foundation for Research in Rheumatology
- Medac
- National Institutes of Health
- EMD Serono
- Chugai Pharmaceutical
- Daiichi Sankyo Europe
- Cilag